We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...
Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...
Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.
Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...
3don MSN
Meanwhile, a suit filed against Cigna in California says the insurer denied over 300,000 claims in two months—about 1.2 ...
Elevance Health (ELV) stock rises as CFO cites underestimated Q1 profit forecasts from analysts for the company at Barclays ...
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...
Health insurers, including Cigna, Humana and Elevance Health, are tucking changes to DEI strategies and business risks into ...
In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results